Basic info
Industry
biotechnology research
Sectors
Biotechnology
Neuroscience
brain injury
Health Care
Medical
medical device
neurology
parkinson's disease
Date founded
2020
Funding rounds raised
Total raised
$40M
from 3 investors over 3 rounds
I
Innervace raised $40M on September 8, 2022
Investors: Wisconsin Alumni Research Foundation, IP Group plc and BioAdvance